Good morning, everyone, and how are you today? Scurrying about to get caught up? We understand. Besides the usual routine of deadlines and phone calls, our own schedule includes yet another meeting and still more documents to peruse. To help us along, yes, we are reaching for that mandatory cup of stimulation - Southern Pecan is on the menu - and invite you to join us. Meanwhile, here are some tidbits. Hope you achieve your goals and see you soon...
Glaxo Commits $800M Investment In UK Manufacturing (Reuters)
UK Court Rules AstraZeneca Seroquel XR Patent Is Invalid (Associated Press)
Merck Flushing Drug May Tackle Baldness (Bloomberg News)
Congress Probes Pharmacy Ties To Drug Shortages (Reuters)
New Cholesterol Meds Are Focus Of Cardiology Meeting (Reuters)
J&J Marketed Vaginal Mesh Implant Without FDA Approval (Bloomberg News)
Tobacco Plants Turn Into Living Vaccines Factories (MSNBC)
Myriad Genetics Investors Worried Over Patent Review (CBS News)
Merck To Refrain From Firings To Cut German Workforce (Bloomberg News)
NicOx Buys A Stake In Altacor (Pharma Times)
Icagen, Now Part Of Pfizer, Gets A New Name (Raleigh News & Observer)
EDITOR'S NOTE: Please check this post for updates throughout the morning
nj train pic thx to slava on flickr